Response to Temozolomide in patients with metastatic melanoma in a third level medical facility

Response to Temozolomide in patients with metastatic melanoma in a third level medical facility

Introduction.Melanoma is a public health problem; it represents 4% of malignant skin tumors and is responsible for 80% of deaths from this type of neoplasm. Objective: Show the response to Temozolomide in patients with metastatic melanoma. Methods: Descriptive, cross-sectional study. The clinical...

Full description

Bibliographic Details
Main Authors: Selene Mejía-Cabrera, Gerardo Marín-Márquez, Fernando Silva-Bravo, Álvaro J. Montiel- Jarquín, Sandra Maldonado-Castañeda, Arturo García-Galicia
Format: Article
Language:Spanish
Published: Universidad Ricardo Palma 2022-03-01
Series:Revista de la Facultad de Medicina Humana
Subjects:
malignant melanoma
metastasis
temozolomide
Online Access:https://revistas.urp.edu.pe/index.php/RFMH/article/view/4788

Internet

https://revistas.urp.edu.pe/index.php/RFMH/article/view/4788

Similar Items